Evidence map›Paper›PMID 40575072›Full record

ArticleGynecologic oncology reports2025

Venous thromboembolism risk for patients with BMI ≥40 kg/m

Kaitlyn G Dinkins, Grace M Lee, Peter W Ketch, Michael D Toboni, Charles A Leath, J Michael Straughn, Teresa K L Boitano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaitlyn G DinkinsDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
Grace M LeeDepartment of Obstetrics and Gynecology, University of Alabama at Birmingham Birmingham, Alabama, United States.
Peter W KetchDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
Michael D ToboniDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
Charles A LeathDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
J Michael StraughnDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.
Teresa K L BoitanoDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Birmingham, Alabama, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To determine the 30-day postoperative incidence of venous thromboembolism (VTE) in patients with endometrial cancer and body mass index (BMI) ≥40 kg/m Methods: This retrospective cohort study included patients undergoing robotic surgery for endometrial cancer from January 2020 to December 2022 with BMI ≥40 kg/m Results: Of the 127 patients included, average BMI was 47 kg/m Conclusion: The rate of 30-day postoperative VTE following robotic staging in patients with class III obesity and endometrial cancer is low. Given this result, these patients do not routinely require extended anticoagulation prophylaxis for VTE prevention upon discharge.

Indexed as

AnticoagulationClass III obesityEndometrial cancerVenous thromboembolism

Identifiers

PMID40575072
PMCPMC12197981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.